Public Health News Roundup: August 12
Kids’ Chronic Stomach Pain Could Be Sign of Anxiety Disorder
Kids with chronic stomach pain without a clear medical explanation— such as inflammatory bowel disease or celiac disorder—are more likely to suffer from an anxiety disorder, according to a new study in the journal Pediatrics. Previous research indicates as many as one in four youth have what is known as functional abdominal pain. Lynn Walker, from the Vanderbilt University School of Medicine in Nashville, Tenn., and researchers found that about 51 percent of people with stomach pain as children had experienced an anxiety disorder and 30 percent at the present met the diagnostic criteria for a diagnosis; only 20 percent of people without stomach pain had experienced an anxiety disorder and 12 percent currently had one. In addition to helping identify present and later anxiety disorders, knowing and treating the issue is also critical for kids because of how the chronic pain can impact their lives and education. "It's very prevalent, and it's one of the most common reasons that children and adolescents end up in their pediatrician's office. It's one of the most common reasons kids are missing school," said Eva Szigethy, MD, head of the Medical Coping Clinic at the Children's Hospital of Pittsburgh Inflammatory Bowel Disease Center. Read more on pediatrics.
Study: Genetic Overlap in Common Mental Disorders
A shared, common inherited genetic variation was seen in an analysis of five major mental disorders, which could ultimately help improve the classification and treatment of the disorders, according to a new study in the journal Nature Genetics. The greatest overlap was between schizophrenia and bipolar disorder with about 15 percent, followed by bipolar disorder and depression with about 10 percent; attention-deficit/hyperactivity disorder and depression with about 10 percent; and schizophrenia and autism with about 3 percent. Researchers noted that as they only looked at common gene variants, the actually genetic overlap could be much greater. "Such evidence quantifying shared genetic risk factors among traditional psychiatric diagnoses will help us move toward classification that will be more faithful to nature," said Bruce Cuthbert, director of the U.S. National Institute of Mental Health's (NIMH) adult translational research and treatment development division, as well as coordinator of an NIMH project to develop a mental disorders classification system for research based more on underlying causes. Read more on mental health.
FDA: Nationwide Voluntary Recall of Drug to Treat Low Calcium
The U.S. Food and Drug Administration has announced a nationwide voluntary recall of all products for sterile use manufactured by Specialty Compounding, LLC, of Cedar Park, Texas, related to possible bacterial bloodstream infections due to calcium gluconate infusions. The drug, which is used to treat low calcium levels, has been linked to 15 infections in two Texas hospitals. Facilities, health care providers and patients who have received the products after May9 should immediately quarantine them and return them to the manufacturer. The products were shipped to patients, hospitals and physicians’ offices, depending on the area of the country. “The FDA believes that use of these products would create an unacceptable risk for patients," said Janet Woodcock, M.D., director of FDA’s Center for Drug Evaluation and Research. "Giving a patient a contaminated injectable drug could result in a life-threatening infection.” Read more on infectious disease.